
1. plos one. 2015 sep 14;10(9):e0137440. doi: 10.1371/journal.pone.0137440.
ecollection 2015.

prevalence dhfr dhps mutations among pregnant women rural burkina
faso five years introduction intermittent preventive treatment 
sulfadoxine-pyrimethamine.

tahita mc(1), tinto h(2), erhart a(3), kazienga a(4), fitzhenry r(3), vanovermeir
c(3), rosanas-urgell a(3), ouedraogo jb(5), guiguemde rt(6), van geertruyden
jp(7), d'alessandro u(8).

author information: 
(1)institut de recherche en sciences de la santé/direction régionale de l'ouest
(irss/dro), bobo-dioulasso, burkina faso; clinical research unit nanoro
(irss-crun), nanoro, burkina faso; unité de recherche sur le paludisme et
maladies tropicales négligées, centre muraz, bobo-dioulasso, burkina faso;
malariology unit, institute tropical medicine (itm), antwerp, belgium;
international health unit, university antwerp, antwerp, belgium.
(2)institut de recherche en sciences de la santé/direction régionale de l'ouest
(irss/dro), bobo-dioulasso, burkina faso; clinical research unit nanoro
(irss-crun), nanoro, burkina faso; unité de recherche sur le paludisme et
maladies tropicales négligées, centre muraz, bobo-dioulasso, burkina faso.
(3)malariology unit, institute tropical medicine (itm), antwerp, belgium.
(4)clinical research unit nanoro (irss-crun), nanoro, burkina faso.
(5)institut de recherche en sciences de la santé/direction régionale de l'ouest
(irss/dro), bobo-dioulasso, burkina faso; clinical research unit nanoro
(irss-crun), nanoro, burkina faso.
(6)clinical research unit nanoro (irss-crun), nanoro, burkina faso; unité de
recherche sur le paludisme et maladies tropicales négligées, centre muraz,
bobo-dioulasso, burkina faso; institut supérieur des sciences de la santé
(inssa), bobo dioulasso, burkina faso.
(7)international health unit, university antwerp, antwerp, belgium.
(8)malariology unit, institute tropical medicine (itm), antwerp, belgium;
london school hygiene tropical medicine, london, united kingdom; medical
research council unit, banjul, gambia.

background: emergence spread drug resistance represents one the
biggest challenges malaria control endemic regions.
sulfadoxine-pyrimethamine (sp) currently deployed intermittent preventive
treatment pregnancy (iptp) prevent adverse effects malaria the
mother offspring. nevertheless, efficacy threatened sp
resistance estimated prevalence dihydropteroate synthase
(dhps) dihydrofolate reductase (dhfr) mutations. measured among
pregnant women health district nanoro, burkina faso.
methods: june december 2010, two hundred fifty six pregnant women 
the second third trimester, attending antenatal care microscopically
confirmed malaria infection invited participate, regardless malaria
symptoms. blood sample collected filter paper analyzed pcr-rflp
for alleles 51, 59, 108, 164 pfdhfr gene 437, 540 pfdhps
gene.
results: genes successfully genotyped one sample (99.6%;
255/256) dhfr 90.2% (231/256) dhps. dhfr c59r s108n
mutations common, prevalence 61.2% (156/255) 55.7%
(142/255), respectively; 12.2% (31/255) samples also dhfr n51i mutation
while i164l mutation absent. dhps a437g mutation found 34.2%
(79/231) isolates, none carried codon k540e. prevalence of
the dhfr double mutations nrni triple mutations irni 35.7% (91/255)
and 11.4% (29/255), respectively.
conclusion: though mutations pfdhfr pfdhps genes relatively
common, prevalence triple pfdhfr mutation low, indicating
that sp iptp still efficacious burkina faso.

doi: 10.1371/journal.pone.0137440 
pmcid: pmc4569438
pmid: 26368675  [indexed medline]

